Circulating α-Klotho Is Elevated in Breast Cancer and Positively Correlates with IGF-1
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27209257 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Shira Ben Neriah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Breast Neoplasms, Glucuronidase, Carcinoma, Intraductal, Noninfiltrating. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer (BC) is the most commonly diagnosed cancer among women worldwide. Klotho is an anti-aging protein implicated in tumor suppression; however, the relationship between circulating Klotho levels and BC remains unclear. We measured serum Klotho by enzyme-linked immunosorbent assay (ELISA) in 372 participants: 166 patients with BC, 24 patients with ductal carcinoma in situ (DCIS), and 182 controls, and examined its relation to clinicopathological characteristics, including estrogen receptor (ER), progesterone receptor (PR), HER2 and lymph node status, body mass index (BMI), and insulin-like growth factor 1 (IGF-1). Serum Klotho levels were significantly higher in invasive BC and DCIS patients compared with controls (p = 0.003 and p = 0.001, respectively), whereas no significant difference was detected between invasive BC and DCIS. After adjustment for age, Klotho levels remained significantly higher in BC and DCIS patients than in controls. Klotho levels correlated positively with IGF-1 (p = 0.0043), but not with BMI, ER, PR, HER2, or lymph node status. These preliminary findings demonstrate an association between elevated circulating Klotho and BC, as well as a positive relationship between Klotho and IGF-1. Further studies using age-matched cohorts and diagnostic-performance analyses are required to determine whether circulating Klotho has clinical utility as a BC biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
- Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
- Endocrinology Institute, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 5262000, Israel.
ORCID-Profile: Ido Wolf, Tami Rubinek
Zitieren
APA
Ben Neriah, S., Abboud, M., Berlin, A., Hemi, R., Aks, R., Shapira, S., Wolf, I., & Rubinek, T. (2026). Circulating α-Klotho Is Elevated in Breast Cancer and Positively Correlates with IGF-1. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209257
Vancouver
Ben Neriah S, Abboud M, Berlin A, Hemi R, Aks R, Shapira S, et al. Circulating α-Klotho Is Elevated in Breast Cancer and Positively Correlates with IGF-1. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209257
BibTeX
@article{BenNeriah2026,
author = {Ben Neriah, Shira and Abboud, Marana and Berlin, Alla and Hemi, Rina and Aks, Rona and Shapira, Shiran and Wolf, Ido and Rubinek, Tami},
title = {Circulating α-Klotho Is Elevated in Breast Cancer and Positively Correlates with IGF-1},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27209257}
}
EUVIMED